What is Synthon Česká Republika's official website?

Synthon Česká Republika's website is https://www.synthon.com/cz

How many employees are working in Synthon Česká Republika right now?

Synthon Česká Republika has 64 employees.

What is Synthon Česká Republika's industry?

Synthon Česká Republika's industry is Pharmaceutical Manufacturing

Who are Synthon Česká Republika's top competitors?

Synthon Česká Republika's top competitors are , , , , , ,

Synthon Česká Republika company information, Employees & Contact Information

Explore related pages

Synthon Česká Republika email format Synthon Česká Republika management contacts

Related company profiles:

Společnost Synthon s.r.o. v České republice je plně integrovaná pobočka Synthonu, která se věnuje výzkumu, vývoji a výrobě API (aktivní léčivé substance). Hlavními aktivitami pobočky jsou chemický a analytický výzkum a vývoj, pilotní poloprovoz a komerční výrobní provoz. Výrobní zařízení jsou přizpůsobena pro nakládání s látkami s nejvyšším rizikem expozice (OEB), což umožňuje práci s vysoce účinnými aktivními léčivými látkami.

Employees: 64
Founded: -
Address: Brněnská 32/čp.597, Blansko,678 01,czech Republic
Industry: Pharmaceutical Manufacturing
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

In-Vitro Diagnostic Substance Manufacturing

Biological Product (except Diagnostic) Manufacturing
Website: https://www.synthon.com/cz
HQ: Blansko
Competitors: PRO.MED.CS, SPOLCHEMIE - Spolek pro chemickou a hutní výrobu, Amateri.com, Synthon Chile, Státní ústav pro kontrolu léčiv, FARMAK, a.s., SOTIO Biotech, Cosmonde, QUINTA-ANALYTICA, Synthon.

Synthon Česká Republika Questions

News

Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market - PR Newswire Canada

Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market PR Newswire Canada

Goldman Sachs’ investment arm agrees €2bn deal for drugmaker Synthon - Financial Times

Goldman Sachs’ investment arm agrees €2bn deal for drugmaker Synthon Financial Times

Zydus acquires Synthon BV novel cancer drug marketing rights in US - ET Pharma

Zydus acquires Synthon BV novel cancer drug marketing rights in US ET Pharma

BC Partners agrees to sell majority stake in Synthon to Goldman Sachs Alternatives - pehub.com

BC Partners agrees to sell majority stake in Synthon to Goldman Sachs Alternatives pehub.com

Relaxation of Nateglinide-Pyridinecarboxamide Coamorphous Systems to Cocrystals: Synthon Competition with Acid, Amide, and Pyridine Groups - ACS Publications

Relaxation of Nateglinide-Pyridinecarboxamide Coamorphous Systems to Cocrystals: Synthon Competition with Acid, Amide, and Pyridine Groups ACS Publications

Zydus Life shares rise 3% on licencing deal with Synthon; key details - Business Today

Zydus Life shares rise 3% on licencing deal with Synthon; key details Business Today

H-synthon enables asymmetric radical difluoroalkylation for synthesis of chiral difluoromethylated amines - Nature

H-synthon enables asymmetric radical difluoroalkylation for synthesis of chiral difluoromethylated amines Nature

Latham Advises BC Partners on Sale of Majority Stake in Synthon - Latham & Watkins LLP

Latham Advises BC Partners on Sale of Majority Stake in Synthon Latham & Watkins LLP

BC Partners Nears Sale of Synthon to Goldman Sachs Asset Arm - Bloomberg

BC Partners Nears Sale of Synthon to Goldman Sachs Asset Arm Bloomberg

Ethylene as a synthon in carbonylative synthesis - ScienceDirect.com

Ethylene as a synthon in carbonylative synthesis ScienceDirect.com

Metal Vapour Synthesis of an Organometallic Barium(0) Synthon - Wiley Online Library

Metal Vapour Synthesis of an Organometallic Barium(0) Synthon Wiley Online Library

Zydus ties up with Synthon BV for multiple sclerosis drug launch in US - The Economic Times

Zydus ties up with Synthon BV for multiple sclerosis drug launch in US The Economic Times

Understanding the Synthon Preferences in Molecular Ionic Cocrystals of Trimethoprim─An Experimental and Computational Study - ACS Publications

Understanding the Synthon Preferences in Molecular Ionic Cocrystals of Trimethoprim─An Experimental and Computational Study ACS Publications

Facile enantioselective synthesis of multi-substituted norbornanes/norbornenes using a latent synthon strategy - Nature

Facile enantioselective synthesis of multi-substituted norbornanes/norbornenes using a latent synthon strategy Nature

Shape-Aware Synthon Search (SASS) for Virtual Screening of Synthon-Based Chemical Spaces - ACS Publications

Shape-Aware Synthon Search (SASS) for Virtual Screening of Synthon-Based Chemical Spaces ACS Publications

Synthon-based ligand discovery in virtual libraries of over 11 billion compounds - Nature

Synthon-based ligand discovery in virtual libraries of over 11 billion compounds Nature

RLSynC: Offline–Online Reinforcement Learning for Synthon Completion - ACS Publications

RLSynC: Offline–Online Reinforcement Learning for Synthon Completion ACS Publications

Tetramethylphosphinane as a new secondary phosphine synthon | Communications Chemistry - Nature

Tetramethylphosphinane as a new secondary phosphine synthon | Communications Chemistry Nature

A short peptide synthon for liquid–liquid phase separation - Nature

A short peptide synthon for liquid–liquid phase separation Nature

Netherlands: BC Partners sells stake in Synthon to Goldman Sachs Alternatives for reported US$2bn valuation - Investors in Healthcare

Netherlands: BC Partners sells stake in Synthon to Goldman Sachs Alternatives for reported US$2bn valuation Investors in Healthcare

Zydus Lifesciences shares in focus on licensing deal with Synthon for generic ZEPOSIA in US market - The Economic Times

Zydus Lifesciences shares in focus on licensing deal with Synthon for generic ZEPOSIA in US market The Economic Times

Zydus Lifesciences shares gain on signing licensing agreement with Synthon - Moneycontrol

Zydus Lifesciences shares gain on signing licensing agreement with Synthon Moneycontrol

Goldman Sachs set to pay €2 billion for Dutch pharma firm Synthon International - NL Times

Goldman Sachs set to pay €2 billion for Dutch pharma firm Synthon International NL Times

Synthon succeeds with Brinkhof and BarentsKrans in jurisidiction claim against Teva - JUVE Patent

Synthon succeeds with Brinkhof and BarentsKrans in jurisidiction claim against Teva JUVE Patent

Chlorodifluoromethane as a C1 Synthon in the Assembly of N -Containing Compounds - ScienceDirect.com

Chlorodifluoromethane as a C1 Synthon in the Assembly of N -Containing Compounds ScienceDirect.com

BC Partners eyes Synthon exit amid selling spree - Financial News London

BC Partners eyes Synthon exit amid selling spree Financial News London

Zydus enters into licensing and supply agreement with Synthon BV - Business Standard

Zydus enters into licensing and supply agreement with Synthon BV Business Standard

Zydus Ties Up With Synthon for MS Drug in US - Construction World India

Zydus Ties Up With Synthon for MS Drug in US Construction World India

Antibody-drug conjugates (ADCs): an interview with Dr Marco Timmers, CSO at Synthon Biopharmaceuticals - News-Medical

Antibody-drug conjugates (ADCs): an interview with Dr Marco Timmers, CSO at Synthon Biopharmaceuticals News-Medical

Zydus, Synthon sign licensing and supply pact for Palbociclib Tablets for US market - Express Pharma

Zydus, Synthon sign licensing and supply pact for Palbociclib Tablets for US market Express Pharma

Zydus Lifesciences inks pact with Synthon for new cancer treatment product - Zee Business

Zydus Lifesciences inks pact with Synthon for new cancer treatment product Zee Business

Companies like Synthon Česká Republika

Top Synthon Česká Republika Employees

Michaela Sykorova (Chvátalová)

Financial Controller Ve Společnosti Synthon Česká Republika

N/a

View
Gabriela Štamberová

Operational Project Manager Ve Společnosti Synthon

Blansko, South Moravia, Czechia, Czech Republic

View

1
synthon.com
Tomáš Cikrle

Manager Of Production Technology At Synthon S.R.O.

Brno, South Moravia, Czechia, Czech Republic

View

2
synthon.com, synthon.com
Petr Brenkus

There Is Human Being Behind Everything In It.

South Moravia, Czechia, Czech Republic

View

1
igwpower.com

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Synthon Česká Republika company information, Employees & Contact Information

Explore related pages

Company Details

Synthon Česká Republika Questions

What is Synthon Česká Republika's official website?

What is Synthon Česká Republika's LinkedIn profile?

How many employees are working in Synthon Česká Republika right now?

What is Synthon Česká Republika's industry?

What are Synthon Česká Republika's top competitors?

What are Synthon Česká Republika's categories?

When was Synthon Česká Republika founded?

News

Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market - PR Newswire Canada

Goldman Sachs’ investment arm agrees €2bn deal for drugmaker Synthon - Financial Times

Zydus acquires Synthon BV novel cancer drug marketing rights in US - ET Pharma

BC Partners agrees to sell majority stake in Synthon to Goldman Sachs Alternatives - pehub.com

Relaxation of Nateglinide-Pyridinecarboxamide Coamorphous Systems to Cocrystals: Synthon Competition with Acid, Amide, and Pyridine Groups - ACS Publications

Zydus Life shares rise 3% on licencing deal with Synthon; key details - Business Today

H-synthon enables asymmetric radical difluoroalkylation for synthesis of chiral difluoromethylated amines - Nature

Latham Advises BC Partners on Sale of Majority Stake in Synthon - Latham & Watkins LLP

BC Partners Nears Sale of Synthon to Goldman Sachs Asset Arm - Bloomberg

Ethylene as a synthon in carbonylative synthesis - ScienceDirect.com

Metal Vapour Synthesis of an Organometallic Barium(0) Synthon - Wiley Online Library

Zydus ties up with Synthon BV for multiple sclerosis drug launch in US - The Economic Times

Understanding the Synthon Preferences in Molecular Ionic Cocrystals of Trimethoprim─An Experimental and Computational Study - ACS Publications

Facile enantioselective synthesis of multi-substituted norbornanes/norbornenes using a latent synthon strategy - Nature

Shape-Aware Synthon Search (SASS) for Virtual Screening of Synthon-Based Chemical Spaces - ACS Publications

Synthon-based ligand discovery in virtual libraries of over 11 billion compounds - Nature

RLSynC: Offline–Online Reinforcement Learning for Synthon Completion - ACS Publications

Tetramethylphosphinane as a new secondary phosphine synthon | Communications Chemistry - Nature

A short peptide synthon for liquid–liquid phase separation - Nature

Netherlands: BC Partners sells stake in Synthon to Goldman Sachs Alternatives for reported US$2bn valuation - Investors in Healthcare

Zydus Lifesciences shares in focus on licensing deal with Synthon for generic ZEPOSIA in US market - The Economic Times

Zydus Lifesciences shares gain on signing licensing agreement with Synthon - Moneycontrol

Goldman Sachs set to pay €2 billion for Dutch pharma firm Synthon International - NL Times

Synthon succeeds with Brinkhof and BarentsKrans in jurisidiction claim against Teva - JUVE Patent

Chlorodifluoromethane as a C1 Synthon in the Assembly of N -Containing Compounds - ScienceDirect.com

BC Partners eyes Synthon exit amid selling spree - Financial News London

Zydus enters into licensing and supply agreement with Synthon BV - Business Standard

Zydus Ties Up With Synthon for MS Drug in US - Construction World India

Antibody-drug conjugates (ADCs): an interview with Dr Marco Timmers, CSO at Synthon Biopharmaceuticals - News-Medical

Zydus, Synthon sign licensing and supply pact for Palbociclib Tablets for US market - Express Pharma

Zydus Lifesciences inks pact with Synthon for new cancer treatment product - Zee Business

Companies like Synthon Česká Republika

Amateri.Com

Synthon

Cosmonde

Sotio Biotech

Státní Ústav Pro Kon...

Pro.Med.Cs

Spolchemie - Spolek ...

Farmak, A.S.

Synthon Chile

Quinta-Analytica

Top Synthon Česká Republika Employees

Michaela Sykorova (Chvátalová)

Financial Controller Ve Společnosti Synthon Česká Republika

Gabriela Štamberová

Operational Project Manager Ve Společnosti Synthon

Tomáš Cikrle

Manager Of Production Technology At Synthon S.R.O.

Petr Brenkus

There Is Human Being Behind Everything In It.

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data